Review



rabbit polyclonal antibody against caveolin 1  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Proteintech rabbit polyclonal antibody against caveolin 1
    Rabbit Polyclonal Antibody Against Caveolin 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 144 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against caveolin 1/product/Proteintech
    Average 95 stars, based on 144 article reviews
    rabbit polyclonal antibody against caveolin 1 - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    95
    Proteintech rabbit polyclonal antibody against caveolin 1
    Rabbit Polyclonal Antibody Against Caveolin 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against caveolin 1/product/Proteintech
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal antibody against caveolin 1 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    90
    Becton Dickinson rabbit polyclonal antibody against caveolin-1
    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest <t>(caveolin-1,</t> BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.
    Rabbit Polyclonal Antibody Against Caveolin 1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against caveolin-1/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody against caveolin-1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit polyclonal antibodies against caveolin 1
    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest <t>(caveolin-1,</t> BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.
    Rabbit Polyclonal Antibodies Against Caveolin 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies against caveolin 1/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal antibodies against caveolin 1 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal antibodies against caveolin-1 (n-20
    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest <t>(caveolin-1,</t> BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.
    Rabbit Polyclonal Antibodies Against Caveolin 1 (N 20, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies against caveolin-1 (n-20/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibodies against caveolin-1 (n-20 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit polyclonal antibody against cav 1
    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest <t>(caveolin-1,</t> BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.
    Rabbit Polyclonal Antibody Against Cav 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against cav 1/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    rabbit polyclonal antibody against cav 1 - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit anti rat polyclonal antibody against cav 1
    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest <t>(caveolin-1,</t> BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.
    Rabbit Anti Rat Polyclonal Antibody Against Cav 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti rat polyclonal antibody against cav 1/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    rabbit anti rat polyclonal antibody against cav 1 - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    90
    OriGene rabbit polyclonal antibody against caveolin 1
    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest <t>(caveolin-1,</t> BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.
    Rabbit Polyclonal Antibody Against Caveolin 1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against caveolin 1/product/OriGene
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody against caveolin 1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson rabbit anti-caveolin-1 polyclonal antibody cav-1 (pab) against caveolin-1 residues 1-97
    A . Western blotting of <t>caveolin-1</t> from ten areas were examined including frontal cortex (Fr), parietal cortex (Par), temporal cortex (Te), occipital cortex (Oc), cerebellum (Ce), thalamus (Th), substantial nigra (Sn), putamen (Put), globus pallidus (Gp), and hippocampus (Hip). B . Western blotting of caveolin-1 between non-CJD and CJD patients. β-actin was used as to monitor amount of samples loaded in each lane. C . Western blotting of caveolin-1 of normal human brain homogenate from non-linear sucrose gradient sedimentation fractions. All Western blots are representative of three independent experiments.
    Rabbit Anti Caveolin 1 Polyclonal Antibody Cav 1 (Pab) Against Caveolin 1 Residues 1 97, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-caveolin-1 polyclonal antibody cav-1 (pab) against caveolin-1 residues 1-97/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    rabbit anti-caveolin-1 polyclonal antibody cav-1 (pab) against caveolin-1 residues 1-97 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal antibody against caveolin-1
    A . Western blotting of <t>caveolin-1</t> from ten areas were examined including frontal cortex (Fr), parietal cortex (Par), temporal cortex (Te), occipital cortex (Oc), cerebellum (Ce), thalamus (Th), substantial nigra (Sn), putamen (Put), globus pallidus (Gp), and hippocampus (Hip). B . Western blotting of caveolin-1 between non-CJD and CJD patients. β-actin was used as to monitor amount of samples loaded in each lane. C . Western blotting of caveolin-1 of normal human brain homogenate from non-linear sucrose gradient sedimentation fractions. All Western blots are representative of three independent experiments.
    Rabbit Polyclonal Antibody Against Caveolin 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against caveolin-1/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody against caveolin-1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest (caveolin-1, BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.

    Journal: PLoS ONE

    Article Title: Involvement of Microtubular Network and Its Motors in Productive Endocytic Trafficking of Mouse Polyomavirus

    doi: 10.1371/journal.pone.0096922

    Figure Lengend Snippet: Non-transfected 3T6 cells (A and E) or cells transiently expressing EGFP-tagged marker of interest (B–D) were infected with MPyV (MOI of 5×10 2 virus particles per cell) and fixed 5 h p.i. Cells were immunostained for MPyV VP1 capsid protein (red) and for a second marker of interest (caveolin-1, BiP) if not fused with EGFP (green). Confocal sections of cells with enlarged details are shown. Arrowheads point to selected MPyV virions co-localized with the marker of interest. Arrows point to selected MPyV that did not co-localize with the marker of interest. Bars, 10 µm. (F) Quantification of co-localization of MPyV virions with indicated markers at 5 h p.i. in non-treated cells (control) or cells pre-treated (1 h) and infected in the presence of nocodazole (Noc) or latrunculin A (LatA). (G) Quantification of co-localization of MPyV virions with EGFP-Rab5 at 1.5 h p.i., in control, Noc- or LatA-treated cells. The percentage of co-localizing virions was calculated from images such as those showed in A–E. During the experiment, more than 600 virions in at least 10 different cells were evaluated for each sample. Data in the graph represent mean values ± s.d. from three independent experiments.

    Article Snippet: Ultrathin cryosections were transferred in a drop of 2.3M sucrose, 2% methylcellulose onto formwar-carbon-coated nickel grids and immunolabeled with rabbit polyclonal antibody against caveolin-1 (BD Transduction Laboratories, BD Biosciences), followed by incubation with goat anti-rabbit antibody conjugated to 10 nm gold particles (British Biocell Int.).

    Techniques: Transfection, Expressing, Marker, Infection

    3T6 cells were pre-treated (1 h) with nocodazole, infected with MPyV in the presence of the drug and fixed 5 h p.i. (A) Cells immunostained for MPyV VP1 (red) and caveolin-1 (green). (B) Cells expressing EGFP-fused Rab7 GTPase (green) immunostained for VP1 protein (red). Confocal sections of cells are shown. Arrowheads point to selected MPyV virions co-localizing with indicated marker. Bars, 10 µm. (C and D) Immunolabeling of thawed cryosections of cells with anti-caveolin-1 antibody, followed by immunolabeling with secondary antibody conjugated with 10 nm gold particles (seen as darkly stained dots). Arrowheads point to selected virions. Empty arrowheads point to flask-shape “empty” caveolar structures. Bars, 100 nm. Pm, plasma membrane; MVBs, multivesicular bodies.

    Journal: PLoS ONE

    Article Title: Involvement of Microtubular Network and Its Motors in Productive Endocytic Trafficking of Mouse Polyomavirus

    doi: 10.1371/journal.pone.0096922

    Figure Lengend Snippet: 3T6 cells were pre-treated (1 h) with nocodazole, infected with MPyV in the presence of the drug and fixed 5 h p.i. (A) Cells immunostained for MPyV VP1 (red) and caveolin-1 (green). (B) Cells expressing EGFP-fused Rab7 GTPase (green) immunostained for VP1 protein (red). Confocal sections of cells are shown. Arrowheads point to selected MPyV virions co-localizing with indicated marker. Bars, 10 µm. (C and D) Immunolabeling of thawed cryosections of cells with anti-caveolin-1 antibody, followed by immunolabeling with secondary antibody conjugated with 10 nm gold particles (seen as darkly stained dots). Arrowheads point to selected virions. Empty arrowheads point to flask-shape “empty” caveolar structures. Bars, 100 nm. Pm, plasma membrane; MVBs, multivesicular bodies.

    Article Snippet: Ultrathin cryosections were transferred in a drop of 2.3M sucrose, 2% methylcellulose onto formwar-carbon-coated nickel grids and immunolabeled with rabbit polyclonal antibody against caveolin-1 (BD Transduction Laboratories, BD Biosciences), followed by incubation with goat anti-rabbit antibody conjugated to 10 nm gold particles (British Biocell Int.).

    Techniques: Infection, Expressing, Marker, Immunolabeling, Staining

    Thawed cryosections were immunolabeled with anti-caveolin-1 antibody followed by incubation with secondary antibody conjugated with 10 nm gold particles. Arrowheads point to selected virions. Bars, 100 nm. Pm, plasma membrane; MVBs, multivesicular bodies; MLB, multilamellar body; Nu, nucleus.

    Journal: PLoS ONE

    Article Title: Involvement of Microtubular Network and Its Motors in Productive Endocytic Trafficking of Mouse Polyomavirus

    doi: 10.1371/journal.pone.0096922

    Figure Lengend Snippet: Thawed cryosections were immunolabeled with anti-caveolin-1 antibody followed by incubation with secondary antibody conjugated with 10 nm gold particles. Arrowheads point to selected virions. Bars, 100 nm. Pm, plasma membrane; MVBs, multivesicular bodies; MLB, multilamellar body; Nu, nucleus.

    Article Snippet: Ultrathin cryosections were transferred in a drop of 2.3M sucrose, 2% methylcellulose onto formwar-carbon-coated nickel grids and immunolabeled with rabbit polyclonal antibody against caveolin-1 (BD Transduction Laboratories, BD Biosciences), followed by incubation with goat anti-rabbit antibody conjugated to 10 nm gold particles (British Biocell Int.).

    Techniques: Immunolabeling, Incubation

    (A) 3T6 cells were pre-treated in culture medium alone or in medium supplemented with nocodazole for 1 h at 37°C and incubated with MPyV (MOI of 5×10 2 virus particles/cell) for 15 or 90 min at 37°C, also in the presence or absence of the drug. After that, immunofluorescence analysis was performed using an anti-MPyV VP1 antibody added to live cells, followed by fixation. Confocal sections of representative cells are shown. Bars, 10 µm. (B) Immunolabeling of thawed cryosections of cells pre-treated and infected with MPyV in the presence of nocodazole. Cells were immunolabeled with anti-caveolin-1 antibody, followed by immunolabeling with secondary antibody conjugated with 10 nm gold particles (seen as darkly stained dots). Arrowheads point to selected virions. Empty arrowhead points to caveolar invagination. Asterisk indicates virion internalizing to an invagination lacking caveolin-1. Arrow points to virion internalizing via a region at the plasma membrane enriched for caveolin-1. Pm, plasma membrane. Bars, 50 nm. (C) 3T6 cells were pre-treated (1 h) with nocodazole and infected with MPyV. The drug was washed out at 7 h p.i. and cells were further incubated until 24 h p.i. (middle bar) or for additional 24 h after washing (right bar). As a control, cells were infected in the absence of the drug and fixed 24 h p.i. Cells were immunostained for MPyV LT antigen and the efficiency of infection was determined by the levels (%) of LT antigen-positive cells, normalized to that in control. During the experiment, at least 500 cells of each sample were counted. Data in the graph represent mean values ± s.d. from three independent experiments. Immunofluorescent staining of microtubules (anti-α-tubulin antibody; panel on the right) shows the morphology of microtubular network at the time of washing (7 h p.i.) in control or nocodazole-treated cells. Bars, 10 µm.

    Journal: PLoS ONE

    Article Title: Involvement of Microtubular Network and Its Motors in Productive Endocytic Trafficking of Mouse Polyomavirus

    doi: 10.1371/journal.pone.0096922

    Figure Lengend Snippet: (A) 3T6 cells were pre-treated in culture medium alone or in medium supplemented with nocodazole for 1 h at 37°C and incubated with MPyV (MOI of 5×10 2 virus particles/cell) for 15 or 90 min at 37°C, also in the presence or absence of the drug. After that, immunofluorescence analysis was performed using an anti-MPyV VP1 antibody added to live cells, followed by fixation. Confocal sections of representative cells are shown. Bars, 10 µm. (B) Immunolabeling of thawed cryosections of cells pre-treated and infected with MPyV in the presence of nocodazole. Cells were immunolabeled with anti-caveolin-1 antibody, followed by immunolabeling with secondary antibody conjugated with 10 nm gold particles (seen as darkly stained dots). Arrowheads point to selected virions. Empty arrowhead points to caveolar invagination. Asterisk indicates virion internalizing to an invagination lacking caveolin-1. Arrow points to virion internalizing via a region at the plasma membrane enriched for caveolin-1. Pm, plasma membrane. Bars, 50 nm. (C) 3T6 cells were pre-treated (1 h) with nocodazole and infected with MPyV. The drug was washed out at 7 h p.i. and cells were further incubated until 24 h p.i. (middle bar) or for additional 24 h after washing (right bar). As a control, cells were infected in the absence of the drug and fixed 24 h p.i. Cells were immunostained for MPyV LT antigen and the efficiency of infection was determined by the levels (%) of LT antigen-positive cells, normalized to that in control. During the experiment, at least 500 cells of each sample were counted. Data in the graph represent mean values ± s.d. from three independent experiments. Immunofluorescent staining of microtubules (anti-α-tubulin antibody; panel on the right) shows the morphology of microtubular network at the time of washing (7 h p.i.) in control or nocodazole-treated cells. Bars, 10 µm.

    Article Snippet: Ultrathin cryosections were transferred in a drop of 2.3M sucrose, 2% methylcellulose onto formwar-carbon-coated nickel grids and immunolabeled with rabbit polyclonal antibody against caveolin-1 (BD Transduction Laboratories, BD Biosciences), followed by incubation with goat anti-rabbit antibody conjugated to 10 nm gold particles (British Biocell Int.).

    Techniques: Incubation, Immunofluorescence, Immunolabeling, Infection, Staining

    A . Western blotting of caveolin-1 from ten areas were examined including frontal cortex (Fr), parietal cortex (Par), temporal cortex (Te), occipital cortex (Oc), cerebellum (Ce), thalamus (Th), substantial nigra (Sn), putamen (Put), globus pallidus (Gp), and hippocampus (Hip). B . Western blotting of caveolin-1 between non-CJD and CJD patients. β-actin was used as to monitor amount of samples loaded in each lane. C . Western blotting of caveolin-1 of normal human brain homogenate from non-linear sucrose gradient sedimentation fractions. All Western blots are representative of three independent experiments.

    Journal: Oncotarget

    Article Title: Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains

    doi: 10.18632/oncotarget.19431

    Figure Lengend Snippet: A . Western blotting of caveolin-1 from ten areas were examined including frontal cortex (Fr), parietal cortex (Par), temporal cortex (Te), occipital cortex (Oc), cerebellum (Ce), thalamus (Th), substantial nigra (Sn), putamen (Put), globus pallidus (Gp), and hippocampus (Hip). B . Western blotting of caveolin-1 between non-CJD and CJD patients. β-actin was used as to monitor amount of samples loaded in each lane. C . Western blotting of caveolin-1 of normal human brain homogenate from non-linear sucrose gradient sedimentation fractions. All Western blots are representative of three independent experiments.

    Article Snippet: Anti-PrP antibody 3F4 (PrP107-112) [ ], Rabbit anti-caveolin-1 polyclonal antibody Cav-1 (pAb) against caveolin-1 residues 1-97 (BD Biosciences), rabbit monoclonal antibody Cav-1 (N-20) against caveolin-1 residues1-20 (Epitomics), and C-term against caveolin-1 residues 167-178 (antibodies-online Inc, Atlanta, GA) were used.

    Techniques: Western Blot, Sedimentation

    A . Western blotting of caveolin-1 in both detergent-soluble and- insoluble fractions probed with anti-caveolin-1 antibody. B . Western blotting of total caveolin-1 (S1), detergent-soluble (S2) and detergent-insoluble (P2) fractions from size exclusion chromatography (FPLC) probed with anti-caveolin-1 antibody. C . Chromatogram of size exclusion chromatography of human brain homogenate from a non-CJD patient. D . 2D electrophoresis analysis of caveolin-1 from insoluble fraction. The caveolin-1 recovered in soluble fraction is shown in the insert box. The above Western blots are representative of three independent experiments.

    Journal: Oncotarget

    Article Title: Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains

    doi: 10.18632/oncotarget.19431

    Figure Lengend Snippet: A . Western blotting of caveolin-1 in both detergent-soluble and- insoluble fractions probed with anti-caveolin-1 antibody. B . Western blotting of total caveolin-1 (S1), detergent-soluble (S2) and detergent-insoluble (P2) fractions from size exclusion chromatography (FPLC) probed with anti-caveolin-1 antibody. C . Chromatogram of size exclusion chromatography of human brain homogenate from a non-CJD patient. D . 2D electrophoresis analysis of caveolin-1 from insoluble fraction. The caveolin-1 recovered in soluble fraction is shown in the insert box. The above Western blots are representative of three independent experiments.

    Article Snippet: Anti-PrP antibody 3F4 (PrP107-112) [ ], Rabbit anti-caveolin-1 polyclonal antibody Cav-1 (pAb) against caveolin-1 residues 1-97 (BD Biosciences), rabbit monoclonal antibody Cav-1 (N-20) against caveolin-1 residues1-20 (Epitomics), and C-term against caveolin-1 residues 167-178 (antibodies-online Inc, Atlanta, GA) were used.

    Techniques: Western Blot, Size-exclusion Chromatography, Two-Dimensional Gel Electrophoresis

    A . Western blotting of brain homogenates from the frontal cortex of CJD and non-CJD patients treated with PK at different concentrations ranging from 0 to 2,000 μg/ml probing with anti-caveolin-1 antibody. B . Brain homogenate from a sCJD patient treated with different amounts of PK probing with anti-caveolin-1 or anti-PrP antibody 3F4. The above Western blots are representative of three independent experiments.

    Journal: Oncotarget

    Article Title: Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains

    doi: 10.18632/oncotarget.19431

    Figure Lengend Snippet: A . Western blotting of brain homogenates from the frontal cortex of CJD and non-CJD patients treated with PK at different concentrations ranging from 0 to 2,000 μg/ml probing with anti-caveolin-1 antibody. B . Brain homogenate from a sCJD patient treated with different amounts of PK probing with anti-caveolin-1 or anti-PrP antibody 3F4. The above Western blots are representative of three independent experiments.

    Article Snippet: Anti-PrP antibody 3F4 (PrP107-112) [ ], Rabbit anti-caveolin-1 polyclonal antibody Cav-1 (pAb) against caveolin-1 residues 1-97 (BD Biosciences), rabbit monoclonal antibody Cav-1 (N-20) against caveolin-1 residues1-20 (Epitomics), and C-term against caveolin-1 residues 167-178 (antibodies-online Inc, Atlanta, GA) were used.

    Techniques: Western Blot

    A . Western blotting of detergent-soluble (S2) and detergent-insoluble (P2) caveolin-1 molecules after PK-treatment in sCJD and non-CJD cases probing with anti-caveolin-1 antibody. The untreated caveolin-1 migrated between 23 and 24 kDa and PK-treated one migrated between 19 and 20 kDa. B . The α- and β-isoforms of caveolin-1 from both S2 and P2 fractions migrated between 22 and 24 kDa without PK treatment, two bands migrating between ˜19 and 21 KDa treated with PK at 5 μg/ml, only one band migrating at ˜19-20 KDa was detectable in the samples treated with PK at 25 μg/ml or higher. The above Western blots are representative of three independent experiments.

    Journal: Oncotarget

    Article Title: Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains

    doi: 10.18632/oncotarget.19431

    Figure Lengend Snippet: A . Western blotting of detergent-soluble (S2) and detergent-insoluble (P2) caveolin-1 molecules after PK-treatment in sCJD and non-CJD cases probing with anti-caveolin-1 antibody. The untreated caveolin-1 migrated between 23 and 24 kDa and PK-treated one migrated between 19 and 20 kDa. B . The α- and β-isoforms of caveolin-1 from both S2 and P2 fractions migrated between 22 and 24 kDa without PK treatment, two bands migrating between ˜19 and 21 KDa treated with PK at 5 μg/ml, only one band migrating at ˜19-20 KDa was detectable in the samples treated with PK at 25 μg/ml or higher. The above Western blots are representative of three independent experiments.

    Article Snippet: Anti-PrP antibody 3F4 (PrP107-112) [ ], Rabbit anti-caveolin-1 polyclonal antibody Cav-1 (pAb) against caveolin-1 residues 1-97 (BD Biosciences), rabbit monoclonal antibody Cav-1 (N-20) against caveolin-1 residues1-20 (Epitomics), and C-term against caveolin-1 residues 167-178 (antibodies-online Inc, Atlanta, GA) were used.

    Techniques: Western Blot

    Both pAb (Cav-1) against residues1-97 and Cav-1 (N-20) against residues 1-20 detected caveolin-1 in A . A431 cell line and B . human brain tissues. Arrows represent α- and β-isoforms of caveolin-1, respectively, in A . Arrow heads represent full-length or truncated forms in B . The above Western blots are representative of three independent experiments.

    Journal: Oncotarget

    Article Title: Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains

    doi: 10.18632/oncotarget.19431

    Figure Lengend Snippet: Both pAb (Cav-1) against residues1-97 and Cav-1 (N-20) against residues 1-20 detected caveolin-1 in A . A431 cell line and B . human brain tissues. Arrows represent α- and β-isoforms of caveolin-1, respectively, in A . Arrow heads represent full-length or truncated forms in B . The above Western blots are representative of three independent experiments.

    Article Snippet: Anti-PrP antibody 3F4 (PrP107-112) [ ], Rabbit anti-caveolin-1 polyclonal antibody Cav-1 (pAb) against caveolin-1 residues 1-97 (BD Biosciences), rabbit monoclonal antibody Cav-1 (N-20) against caveolin-1 residues1-20 (Epitomics), and C-term against caveolin-1 residues 167-178 (antibodies-online Inc, Atlanta, GA) were used.

    Techniques: Western Blot

    Caveolin-1 from cultured A431 cells or human brain tissues was treated with or without PK prior to Western blotting probed with three different antibodies against caveolin-1. pAb (Cav-1) against residues1-97 and Cav-1 (N-20) against residues 1-20 detected caveolin-1 while antibody C-term that against C-term region of caveolin only detected caveolin-1 from the cultured cells but not from the brains. The above Western blots are representative of three independent experiments.

    Journal: Oncotarget

    Article Title: Characterization of physiochemical properties of caveolin-1 from normal and prion-infected human brains

    doi: 10.18632/oncotarget.19431

    Figure Lengend Snippet: Caveolin-1 from cultured A431 cells or human brain tissues was treated with or without PK prior to Western blotting probed with three different antibodies against caveolin-1. pAb (Cav-1) against residues1-97 and Cav-1 (N-20) against residues 1-20 detected caveolin-1 while antibody C-term that against C-term region of caveolin only detected caveolin-1 from the cultured cells but not from the brains. The above Western blots are representative of three independent experiments.

    Article Snippet: Anti-PrP antibody 3F4 (PrP107-112) [ ], Rabbit anti-caveolin-1 polyclonal antibody Cav-1 (pAb) against caveolin-1 residues 1-97 (BD Biosciences), rabbit monoclonal antibody Cav-1 (N-20) against caveolin-1 residues1-20 (Epitomics), and C-term against caveolin-1 residues 167-178 (antibodies-online Inc, Atlanta, GA) were used.

    Techniques: Cell Culture, Western Blot